| Metric | შპს საფ ფარმა | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾6.4m₾6.5m | ₾2.36bn₾2.11bn |
| Revenue growth | -1.3% | 11.8% |
| Profitability | ||
| EBITDA | ₾1.4m₾1.2m | — |
| EBITDA margin | 22.5%18.4% | — |
| Net profit | ₾1.5m₾1.1m | ₾1.24bn₾1.12bn |
| Net margin | 23.0%17.7% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾5.3m₾5.4m | ₾37.66bn₾31.77bn |
| Total equity | ₾2.7m₾1.2m | ₾5.45bn₾4.75bn |
| ROE | 54.6%93.9% | 22.8%23.6% |